This study evaluates the impact of primary and secondary nonadherence to cholesterol medication on low-density lipoprotein levels, emergency department visits, and hospitalizations.
Janet Shin Lee, PhD
Advertisement
Articles by Janet Shin Lee, PhD
Advertisement
Latest Updated Articles
- Outcomes Associated With Primary and Secondary Nonadherence to Cholesterol Medications
Published: April 18th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
2
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
3
Pharmacy Policy Updates for October 2025
4
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
5
